Express News | Amgen received commercialization rights for Avacopan in Asia and the Americas.

Breakings36minutes ago

What the Options Market Tells Us About Amgen

Financial giants have made a conspicuous bearish move on Amgen. Our analysis of options history for Amgen (NASDAQ:AMGN) revealed 9 unusual trades.Delving into the details, we found 11% of traders were

Benzinga04:01

Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints

Alvotech (ALVO) said Tuesday a confirmatory study for AVT03, a proposed biosimilar to Amgen's (AMGN) denosumab sold as Prolia and Xgeva, met its primary endpoints. The study aims to show clinical simi

MT NewswiresJul 2 22:36

Amgen Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on Amgen.Looking at options history for Amgen (NASDAQ:AMGN) we detected 10 trades.If we consider the specifics of each trade,

BenzingaJul 2 03:02

Watch Now: ETF Edge on Reshoring Trends, Weight Loss Drugs and More

CNBCJul 2 00:15

Alnylam, Lilly, AstraZeneca Among Best Performing Pharmas, Biotechs in Q2

Seeking AlphaJul 1 08:30